CD40LG and infection: We therefore propose that individuals with higher plasma IgM or IgG reactivity to PfARMA may be protected from subsequent symptomatic infection due to broad, recently acquired antibody responses that target multiple parasite antigens, not because of the presence of anti-PfARMA antibodies by itself.